Compare Neurocrine Biosciences Inc (NBIX) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Rush Street Interactive Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Rush Street Interactive Inc trades at $33.46 (market cap $3.55B). The key difference: Neurocrine Biosciences Inc is far larger — about 4.9× Rush Street Interactive Inc's market cap. Which is the better fit depends on your goals.
| NBIX | RSI | |
|---|---|---|
Market Cap | $17.40B | $3.55B |
Sector | Health | Technology |
52-Week High | $180.55 | $34.52 |
52-Week Low | $123.10 | $14.55 |
Enterprise Value | $16.49B | $3.23B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
